Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 20:9:670889.
doi: 10.3389/fpubh.2021.670889. eCollection 2021.

Questionnaire Survey on the Current Situation and Experience in Prevention and Control Measures at Urology Clinics During the COVID-19 Epidemic in China

Affiliations

Questionnaire Survey on the Current Situation and Experience in Prevention and Control Measures at Urology Clinics During the COVID-19 Epidemic in China

Xiao-Liang Zhu et al. Front Public Health. .

Abstract

COVID-19, the coronavirus disease 2019; SARS-CoV-2, the coronavirus 2; ACE2, angiotensin converting enzyme 2; S protein, spiked glycoprotein; TMPRSS2, transmembrane serine protease 2; WHO, World Health Organization. Purpose: Although the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2, has been viably controlled in China, a new normal in healthcare strategies has become standard in China and worldwide. We conducted a questionnaire study to disseminate the experience from China in terms of urology outpatient prevention and control measures under standardized prevention policies against COVID-19. Participants and Methods: From May 3, 2020 to June 25, 2020, we conducted an anonymous cross-sectional questionnaire study, focused on the status of and experiences with outpatient urology prevention and control measures during the COVID-19 pandemic. The targeted respondents were urologists in mainland China, covering all levels of hospitals and clinics. Results: A total of 216 (97%) valid responses were collected. We found that 183 (85%) respondents were from outside of Hubei province in China. One-hundred-and-fifty-eight (73%) respondents believed that SARS-CoV-2 could be detected in urine, and that protection against urine exposure was needed. Over 80% of respondents recommended WeChat application or similar online video meetings for virtual outpatient consultations. The suggested flowcharts and recommendations to prevent new cases were easy to understand and approved by most physicians, which could provide reference for outpatient prevention and control. We still need to make adequate preparations under the new normal of the COVID-19 Epidemic, especially for those suspected of being infected. Conclusions: Although the scientific validation of the questionnaire is limited, it provides a first snapshot of the experiences relating to the prevention and control measures in urology clinics in China, and can inform future policies in this field.

Keywords: COVID-19; SARS-CoV-2; epidemic; experience; questionnaire; urological outpatient.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Outpatient procedures flowchart for screening patients with COVID-19.
Figure 2
Figure 2
Flowchart for wearing protection in outpatient treatment rooms.
Figure 3
Figure 3
Flowchart for wearing protection in outpatient operating rooms.

Similar articles

References

    1. Hertz-Palmor N, Moore TM, Gothelf D, DiDomenico GE, Dekel I, Greenberg DM, et al. . Association among income loss, fina strain and depressive symptoms during COVID-19: evidence from longitudinal studies. J Affect Disord. (2021) 291:1–8. 10.1016/j04.054 - DOI - PMC - PubMed
    1. Teoh JY-C, Ong WLK, Gonzalez-Padilla D, Castellani D, Dubin JM, Esperto F, et al. . A Global survey on the impact of COVID-19 on urological services. Eur Urol. (2020) 78:265–75. 10.1016/j.eururo.2020.05.025 - DOI - PMC - PubMed
    1. Ye Q, Wang B, Mao J, Fu J, Shang S, Shu Q, et al. . Epidemiological analysis of COVID-19 and practical experience from China. J Med Virol. (2020) 92:755–69. 10.1002/jmv.25813 - DOI - PMC - PubMed
    1. Saeed H, Osama H, Madney YM, Harb HS, Abdelrahman MA, Ehrhardt C, et al. . COVID-19; current situation and recommended interventions. Int J Clin Pract. (2021) 75:e13886. 10.1111/ijcp.13886 - DOI - PMC - PubMed
    1. Gao Z, Xu Y, Sun C, Wang X, Guo Y, Qiu S, et al. . A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect. (2021) 54:12–6. 10.1016/j.jmii.2020.05.001 - DOI - PMC - PubMed

Publication types